Rujukan Klorokuin dan hidroksiklorokuin semasa pandemik COVID-19

  1. ↑ "Chloroquine or Hydroxychloroquine". COVID-19 Treatment Guidelines (dalam bahasa Inggeris). National Institutes of Health. Dicapai pada 2021-02-14.
  2. ↑ Commissioner, Office of the (2020-07-17). "Coronavirus (COVID-19) Update: Daily Roundup March 30, 2020". FDA (dalam bahasa Inggeris). Dicapai pada 2021-03-25.
  3. ↑ Smit M, Marinosci A, Agoritsas T, Ford N, Calmy A (January 2021). "Prophylaxis for COVID-19: a systematic review". Clinical Microbiology and Infection (Systematic review). doi:10.1016/j.cmi.2021.01.013.Selenggaraan CS1: menggunakan parameter authors (link)
  4. ↑ Meyerowitz EA, Vannier AG, Friesen MG, Schoenfeld S, Gelfand JA, Callahan MV, dll. (May 2020). "Rethinking the role of hydroxychloroquine in the treatment of COVID-19". FASEB Journal. 34 (5): 6027–6037. doi:10.1096/fj.202000919. PMID 32350928.
  5. ↑ "Information for clinicians on therapeutic options for COVID-19 patients". US Centers for Disease Control and Prevention. 21 March 2020. Dicapai pada 22 March 2020.
  6. ↑ "Request for Emergency Use Authorization For Use of Chloroquine Phosphate or Hydroxychloroquine Sulfate Supplied From the Strategic National Stockpile for Treatment of 2019 Coronavirus Disease" (PDF). U.S. Food and Drug Administration (FDA). 28 March 2020. Dicapai pada 30 March 2020.
  7. ↑ "Coronavirus Disease 2019 (COVID-19)". Centers for Disease Control and Prevention. 11 February 2020. Dicapai pada 9 April 2020.
  8. ↑ "FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems". U.S. Food and Drug Administration (FDA). 24 April 2020.
  9. ↑ "Hydroxychloroquine halted in WHO-sponsored COVID-19 trials". Bloomberg. 2020-06-17. Dicapai pada 2020-06-17.
  10. ↑ Food and Drug Agency (19 Jun 2020). "Frequently Asked Questions on the Revocation of the Emergency Use Authorization for Hydroxychloroquine Sulfate and Chloroquine Phosphate".
  11. ↑ "Revised advisory on the use of Hydroxychloroquine(HCQ) as prophylaxis for SARS-CoV-2 infection(in supersession of previous advisory dated 23rd March, 2020)" (PDF). icmr.gov.in. Indian Council of Medical Research. 22 May 2020. Diarkib (PDF) daripada yang asal pada 23 May 2020. Dicapai pada 3 July 2020.
  12. ↑ "Coronavirus and hydroxychloroquine: What do we know?". bbc.com. BBC. 1 Julai 2020. Diarkib daripada yang asal pada 3 July 2020. Dicapai pada 3 July 2020.
  13. ↑ "Hydroxychloroquine sulfate". Drugs.com. 31 March 2020. Dicapai pada 5 April 2020.
  14. ↑ "NIH Panel Recommends Against Drug Combination Promoted By Trump For COVID-19". NPR. April 21, 2020.
Afrika
Asia
Asia Timur
Asia Tenggara
Asia Selatan
Asia Barat
Asia Utara/Tengah
Eropah
Kawasan Schengen
Amerika Utara
Amerika Syarikat
Oceania
Amerika Selatan
Pengangkutan
antarabangsa
Kuarantin
Institusi
Pusat
Kawalan Penyakit
Hospital dan
berkaitan
Pertubuhan
Isu
Masalah dan
sekatan
Pencegahan
Rawatan
Kesan sosio-ekonomi
Orang
Pakar perubatan
Penyelidik
Pegawai
WHO
Negara
Lain-lain
Kematian
Data
Global
Afrika
Asia
Eropah
Amerika Utara
Oceania
Amerika Selatan

Berkaitan

Rujukan

WikiPedia: Klorokuin dan hidroksiklorokuin semasa pandemik COVID-19 //pubmed.ncbi.nlm.nih.gov/32350928 //doi.org/10.1016%2Fj.cmi.2021.01.013 //doi.org/10.1096%2Ffj.202000919 https://www.bbc.com/news/51980731 https://www.bloomberg.com/news/articles/2020-06-17... https://www.drugs.com/monograph/hydroxychloroquine... https://www.cdc.gov/coronavirus/2019-ncov/hcp/ther... https://www.fda.gov/drugs/drug-safety-and-availabi... https://www.fda.gov/media/136534/download https://www.fda.gov/media/138946/download